/
you're reading...

Additional flexibility for veterinarians as CYTOPOINT® use extended to cover the treatment of pruritus associated with allergic dermatitis in dogs

Zoetis’ antibody therapy, CYTOPOINT®, already approved in the EU for the treatment of clinical manifestations of atopic dermatitis in dogs now has wider application. December 3, 2020 &n...

Read full story

Archives